VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

C. botulinum DNA vaccine pSCARSA/BHc
Vaccine Information
  • Vaccine Name: C. botulinum DNA vaccine pSCARSA/BHc
  • Target Pathogen: Clostridium botulinum
  • Target Disease: Botulism
  • Vaccine Ontology ID: VO_0004166
  • Type: DNA vaccine
  • Status: Research
  • Host Species as Laboratory Animal Model: Mouse
  • Antigen: Clostridium botulinum neurotoxin serotypes A (BoNT/A) and B (BoNT/B) (Yu et al., 2009)
  • BoNT/B gene engineering:
    • Type: DNA vaccine construction
    • Description:
    • Detailed Gene Information: Click Here.
  • BoNT/A1 from C. botulinum A str. Hall gene engineering:
    • Type: DNA vaccine construction
    • Description:
    • Detailed Gene Information: Click Here.
  • DNA vaccine plasmid:
    • DNA vaccine plasmid name:
    • DNA vaccine plasmid VO ID: VO_0000810
  • Immunization Route: Intramuscular injection (i.m.)
Host Response

Mouse Response

  • Vaccine Immune Response Type: VO_0003057
  • Efficacy: Vaccinated mice were challenged with doses of 1000 and 10,000 LD50 of BoNT/A and BoNT/B, and immune protection was observed. 100% of mice (8/8) survived in the group challenged with 1000 LD50, which was significantly higher protection than that of the single pSCARSAHc or pSCARSBHc-vaccinated mice groups, and 87.5% of mice (7/8) survived in the group challenged with 10,000 LD50 (Yu et al., 2009).
References
Yu et al., 2009: Yu Y, Yu J, Li N, Wang S, Yu W, Sun Z. Individual and bivalent vaccines against botulinum neurotoxin serotypes A and B using DNA-based Semliki Forest virus vectors. Vaccine. 2009; 27(44); 6148-6153. [PubMed: 19712769].